Related references
Note: Only part of the references are listed.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Flutemetamol F 18 injection PET images reflect brain beta-amyloid levels
Chris Buckley et al.
Alzheimers & Dementia (2012)
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
T. T. Seppala et al.
NEUROLOGY (2012)
Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature
V. Leinonen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Association Between In Vivo Fluorine 18-Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
David A. Wolk et al.
ARCHIVES OF NEUROLOGY (2011)
Amyloid PET imaging in patients with mild cognitive impairment A 2-year follow-up study
J. Koivunen et al.
NEUROLOGY (2011)
Technical aspects of amyloid imaging for Alzheimer's disease
Paul Edison et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease
Heidi C. Rossetti et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Lack of Shunt Response in Suspected Idiopathic Normal Pressure Hydrocephalus with Alzheimer Disease Pathology
Roy Hamilton et al.
ANNALS OF NEUROLOGY (2010)
Amyloid and Tau Proteins in Cortical Brain Biopsy and Alzheimer's Disease
Ville Leinonen et al.
ANNALS OF NEUROLOGY (2010)
18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
Rik Vandenberghe et al.
ANNALS OF NEUROLOGY (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent - a pilot study
Kun-Ju Lin et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Amyloid Imaging in Mild Cognitive Impairment Subtypes
David A. Wolk et al.
ANNALS OF NEUROLOGY (2009)
Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B
Martha Storandt et al.
ARCHIVES OF NEUROLOGY (2009)
Update on amyloid imaging: From healthy aging to Alzheimer's disease
David A. Wolk et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
Natalie Nelissen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Biopsy support for the validity of Pittsburgh Compound B positron emission tomography with a twist
William E. Klunk
ARCHIVES OF NEUROLOGY (2008)
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B
Ville Leinonen et al.
ARCHIVES OF NEUROLOGY (2008)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
PET Amyloid Ligand [C-11]PIB Uptake and Cerebrospinal Fluid beta-Amyloid in Mild Cognitive Impairment
J. Koivunen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B
Cyrus A. Raji et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
Imaging β-amyloid burden in aging and dementia
C. C. Rowe et al.
NEUROLOGY (2007)
Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report
Brian J. Bacskai et al.
ARCHIVES OF NEUROLOGY (2007)
Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
P. Edison et al.
NEUROLOGY (2007)
PET of brain amyloid and tau in mild cognitive impairment
Gary W. Small et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)
Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response
J Golomb et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Share Paper
